CAM

Cormorant Asset Management’s Ascendis Pharma ASND Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$6.11M	–	77
2022 Q4	$6.11M	Hold	50,000	–	–	0.41%	50
2022 Q3	$5.16M	Hold	50,000	–	–	0.36%	52
2022 Q2	$4.65M	Hold	50,000	–	–	0.35%	53
2022 Q1	$5.87M	Hold	50,000	–	–	0.45%	47
2021 Q4	$6.73M	Sell	50,000 -120,000	-71%	-$16.1M	0.4%	50
2021 Q3	$27.1M	Buy	170,000 +95,000	+127%	+$15.1M	1.1%	29
2021 Q2	$9.87M	Sell	75,000 -25,000	-25%	-$3.29M	0.34%	59
2021 Q1	$12.9M	Hold	100,000	–	–	0.29%	61
2020 Q4	$16.7M	Sell	100,000 -25,000	-20%	-$4.17M	0.4%	49
2020 Q3	$19.3M	Sell	125,000 -50,000	-29%	-$7.72M	0.74%	36
2020 Q2	$25.9M	Sell	175,000 -75,000	-30%	-$11.1M	0.99%	27
2020 Q1	$28.2M	Sell	250,000 -150,000	-38%	-$16.9M	1.31%	20
2019 Q4	$55.6M	Sell	400,000 -68,300	-15%	-$9.5M	2.22%	12
2019 Q3	$45.1M	Buy	468,300 +68,300	+17%	+$6.58M	2.75%	7
2019 Q2	$46.1M	Sell	400,000 -200,000	-33%	-$23M	2.65%	11
2019 Q1	$70.6M	Buy	600,000 +261,544	+77%	+$30.8M	4.77%	3
2018 Q4	$21.2M	Sell	338,456 -11,544	-3%	-$723K	1.72%	18
2018 Q3	$24.8M	Sell	350,000 -21,739	-6%	-$1.54M	1.61%	21
2018 Q2	$24.7M	Hold	371,739	–	–	1.83%	19
2018 Q1	$24.3M	Buy	371,739 +71,739	+24%	+$4.69M	1.81%	13
2017 Q4	$12M	Buy	+300,000	New	+$12M	1.26%	22
2017 Q2	–	Sell	-100,000	Closed	-$2.8M	–	71
2017 Q1	$2.8M	Sell	100,000 -62,254	-38%	-$1.74M	0.41%	53
2016 Q4	$3.28M	Buy	162,254 +100,000	+161%	+$2.02M	0.44%	48
2016 Q3	$1.25M	Hold	62,254	–	–	0.14%	69
2016 Q2	$826K	Buy	62,254 +754	+1%	+$10K	0.12%	70
2016 Q1	$1.14M	Hold	61,500	–	–	0.17%	69
2015 Q4	$1.13M	Hold	61,500	–	–	0.13%	67
2015 Q3	$1.09M	Hold	61,500	–	–	0.17%	71
2015 Q2	$1.09M	Hold	61,500	–	–	0.14%	70
2015 Q1	$1.07M	Buy	+61,500	New	+$1.07M	0.16%	61